Protease inhibitors as antiviral agents.
Currently, there are a number of approved antiviral agents for use in the treatment of viral infections. However, many instances exist in which the use of a second antiviral agent would be beneficial because it would allow the option of either an alternative or a combination therapeutic approach. Accordingly, virus-encoded proteases have emerged as new targets for antiviral intervention. Molecular studies have indicated that viral proteases play a critical role in the life cycle of many viruses by effecting the cleavage of high-molecular-weight viral polyprotein precursors to yield functional products or by catalyzing the processing of the structural proteins necessary for assembly and morphogenesis of virus particles. This review summarizes some of the important general features of virus-encoded proteases and highlights new advances and/or specific challenges that are associated with the research and development of viral protease inhibitors. Specifically, the viral proteases encoded by the herpesvirus, retrovirus, hepatitis C virus, and human rhinovirus families are discussed.
Agouron Pharmaceuticals, Inc., San Diego, California 92121, USA. patick@agouron.com
A K
AK
Patick
K E
KE
Potts
D000998:Antiviral Agents / Q000627:therapeutic use*; D015684:Gene Products, pol; D006801:Humans; D011480:Protease Inhibitors / Q000627:therapeutic use*; D014777:Virus Diseases / Q000188:drug therapy*
D000998:Antiviral Agents; D015684:Gene Products, pol; D011480:Protease Inhibitors